Libbey Anne Yates

Title: Libbey Anne Yates: Innovator in 4-1BB Binding Molecules

Introduction

Libbey Anne Yates is a prominent inventor based in Dardenne Prairie, MO (US). She has made significant contributions to the field of biotechnology, particularly in the development of binding molecules that target human 4-1BB. With a total of 4 patents to her name, Yates has established herself as a key figure in her area of expertise.

Latest Patents

Yates' latest patents focus on isolated binding molecules that bind to human 4-1BB. These patents include detailed descriptions of nucleic acid molecules encoding the amino acid sequences of the binding molecules, vectors that comprise these nucleic acid molecules, and host cells that contain the vectors. Additionally, her work outlines methods for producing these binding molecules, pharmaceutical compositions that include them, and various methods for utilizing these binding molecules or compositions.

Career Highlights

Libbey Anne Yates is currently employed at Pfizer Corporation, where she continues to innovate and contribute to the advancement of medical science. Her work has the potential to impact therapeutic approaches in immunology and cancer treatment.

Collaborations

Yates collaborates with talented professionals in her field, including Bianca Ahrens and Sangita M Baxi. These partnerships enhance her research and development efforts, fostering a collaborative environment that drives innovation.

Conclusion

Libbey Anne Yates is a dedicated inventor whose work on 4-1BB binding molecules showcases her commitment to advancing biotechnology. Her contributions are paving the way for new therapeutic options in the medical field.